B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ITGA2B

MOLECULAR TARGET

integrin subunit alpha 2b

UniProt: P08514NCBI Gene: 36741 compounds

ITGA2B (integrin subunit alpha 2b) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ITGA2B

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Tirofiban Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in3.6136

About ITGA2B as a Drug Target

ITGA2B (integrin subunit alpha 2b) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented ITGA2B interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ITGA2B inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.